Diabetes Technology & TherapeuticsVol. 21, No. S1EditorialsFree Access

Technologies in Diabetes–the Tenth ATTD Yearbook

Tadej Battelino

Moshe Phillip

Published Online:20 Feb 2019https://doi.org/10.1089/dia.2019.2500

 

Introduction to ATTD Year Book

After the festive introduction to last year's Advanced Technologies and Treatments for Diabetes (ATTD) Yearbook, when we celebrated the inauguration of (hybrid) closed-loop insulin delivery into everyday clinical reality in the United States, we had to face, as usual in life, the fact that until diabetes is finally cured, we will still have to deal with multiple ongoing challenges. The overwhelming evidence of benefits conveyed by the regular use of continuous glucose monitoring (CGM) highlighted the incomprehensible gap between research and routine care practices. CGM is—surprisingly to many of us—still not the predominant treatment modality despite the overwhelming evidence, mainly because public reimbursement systems in many wealthy Western societies still spend millions of dollars on chronic complications of diabetes rather than investing in better care with the regular use of CGM, thus preventing them.

”There is nothing new under the sun” as the ancient proverb says. It took decades before famous diabetes professors accepted the benefit of self-monitoring of blood glucose. However, the frustration and anger of people with diabetes (PWDs) seems understandable and legitimate. Intermittent (Flash) glucose monitoring made it into several reimbursement systems with lowered prices and public pressure, alleviating some of the imminent need of PWDs. However, the exigent need for more comprehensive reimbursement for diabetes care remains colossal.

Imagine if a majority of PWDs could get CGM reimbursed and could keep their glucose concentration within range most of the time. Time in range is the new reality, a solid clinical outcome to erudite diabetologists and, unfortunately, a mere gimmick to those firmly rooted in denial regarding the damage glucose concentrations outside the near-normal range cause to several organs. The attention that developed societies have recently begun to focus on the human brain seems timely and fundamental also for PWDs. Hyperglycemia and proportion of time above range was firmly associated with damage to the brain in young, adult, and aging populations of PWDs. Cognitive impairment and early dementia may soon represent one of the biggest burdens on our aging societies, both in social and fiscal dimensions. CGM can therefore become a cost-saving treatment modality—just imagine!

Clinicians, diabetes care providers, researchers, industries, investors, reimbursement authorities, and recently most importantly PWDs convene at ATTD annual meetings to infuse some optimism and fairness into the potential novel technologies and treatments for diabetes could bring to many. This ATTD 2018 Yearbook again strives to provide some firm evidence and clarity through the eyes of our expert associate editors and authors of the 13 articles. Please join us in amazement at the wealth of data and insight this ATTD 2018 Yearbook brings to us: diabetes technologies and novel therapies help improve diabetes outcomes ever better and more. That said, PWDs need universal access to and sustained reimbursement of all these proven-efficient therapies.

Our continuous dream has sprouted a new branch: that all people with diabetes might have access to the evidence-based novel treatment modalities. Joined with ATTD, we managed to foster and accelerate research, innovation, and investment into advanced treatments for diabetes; let us now make them available to all who are in obvious need.

Last, but not least, we wish to extend our heartfelt gratitude to our coauthors for sharing their knowledge, expertise, and valuable time in writing their articles in this ATTD Yearbook.

 

Free for you online pdf

Year Book just click down or separate chapters for you

https://www.liebertpub.com/toc/dia/21/S1?utm_source=sfmc&utm_medium=email&utm_campaign=DIA%20FP%20Abstract%20Feb20%202019&d=2/20/2019&mcid=1461189826

Free

Technologies in Diabetes–the Tenth ATTD Yearbook
  • Pages:S-3–S-3
  • Published Online:20 February 2019

https://doi.org/10.1089/dia.2019.2500

Original ArticlesFree

Self-Monitoring of Blood Glucose
  • Pages:S-4–S-12
  • Published Online:20 February 2019

https://doi.org/10.1089/dia.2019.2501

Free

Continuous Glucose Monitoring in 2018
  • Pages:S-13–S-31
  • Published Online:20 February 2019

https://doi.org/10.1089/dia.2019.2502

Free

Insulin Pumps
  • Pages:S-32–S-41
  • Published Online:20 February 2019

https://doi.org/10.1089/dia.2019.2503

Free

Decision Support Systems and Closed Loop
  • Pages:S-42–S-56
  • Published Online:20 February 2019

https://doi.org/10.1089/dia.2019.2504

Free

New Insulins, Biosimilars, and Insulin Therapy
  • Pages:S-57–S-78
  • Published Online:20 February 2019

https://doi.org/10.1089/dia.2019.2505

Free

Using Digital Health Technology to Prevent and Treat Diabetes
  • Pages:S-79–S-94
  • Published Online:20 February 2019

https://doi.org/10.1089/dia.2019.2506

Free

Immune Intervention in Type 1 Diabetes
  • Pages:S-95–S-100
  • Published Online:20 February 2019

https://doi.org/10.1089/dia.2019.2507

Free

Technology and Pregnancy
  • Pages:S-101–S-111
  • Published Online:20 February 2019

https://doi.org/10.1089/dia.2019.2508

Free

Advances in Exercise, Physical Activity, and Diabetes Mellitus
  • Pages:S-112–S-122
  • Published Online:20 February 2019

https://doi.org/10.1089/dia.2019.2509

Free

Diabetes Technology and Therapy in the Pediatric Age Group
  • Pages:S-123–S-137
  • Published Online:20 February 2019

https://doi.org/10.1089/dia.2019.2510

Free

Diabetes Technology and the Human Factor
  • Pages:S-138–S-147
  • Published Online:20 February 2019

https://doi.org/10.1089/dia.2019.2511

Free

Practical Implementation of Diabetes Technology: It Is Time
  • Pages:S-148–S-159
  • Published Online:20 February 2019

https://doi.org/10.1089/dia.2019.2512

Free

New Medications for the Treatment of Diabetes
  • Pages:S-160–S-171
  • Published Online:20 February 2019

https://doi.org/10.1089/dia.2019.2513

AbstractsFree

The Official Journal of ATTD Advanced Technologies & Treatments for Diabetes Conference Berlin, Germany—February 20–23, 2019
  • Pages:A-1–A-164
  • Published Online:20 February 2019

https://doi.org/10.1089/dia.2019.2525.abstracts

Free

ATTD 2019 Abstract Author Index
  • Pages:A-165–A-173
  • Published Online:20 February 2019

https://doi.org/10.1089/dia.2019.2526.abstracts.index

FacebookTwitterLinkedinGoogle Bookmarks